Analgesic Efficacy of Prophylactic Gabapentin and Lornoxicam in Preventing Postendodontic Pain

作者：Isik Berrin^*; Yaman Sis; Aktuna Serkan; Turan Alparslan

来源：Pain Medicine, 2014, 15(12): 2150-2155.

DOI：10.1111/pme.12536

• Prophylactic
• Analgesia
• Lornoxicam
• Gabapentin

ObjectiveIn dental applications, as in all other medical applications, pain needs to be prevented or at least controlled. The use of the tooth as a model for studying pain mechanisms is well established. In the current study, we aimed to evaluate and compare the analgesic effects of gabapentin and lornoxicam, respectively, vs a placebo for postendodontic treatment pain. %26lt;br%26gt;Design and MethodsClinical research was planned as prospective, randomized, and placebo controlled. Each subject was given 600mg gabapentin (group G: N=30), 8mg lornoxicam (group L: N=30), or a placebo (group C: N=30) 30 min prior to endodontic treatment. %26lt;br%26gt;Outcome MeasuresAt 4 (T-3), 8 (T-4), 12 (T-5), and 24 (T-6) h after preoperative (T-0) time points, the analgesic efficacies of the agents were evaluated by using the visual analog scale (VAS). %26lt;br%26gt;ResultsIn group G, VAS values were significantly greater at T-0 time point than at T-5 or T-6. T-0 time point VAS value in group L was lower than at T-4 time point and greater than at T-6. In group C, T-0 time point VAS values were significantly lower at T-3 and T-5 time points and greater than at T-6 time point. VAS values in group G at T-5 time point were significantly lower than in group C or group L (P%26lt;0.05). %26lt;br%26gt;ConclusionsBased on the obtained data, prophylactic lornoxicam controlled postendodontic treatment pain more effectively than did the placebo drugs, and gabapentin was more effective in controlling the pain than either lornoxicam or the placebo.

• 出版日期2014-12